Valuation DexCom, Inc. Deutsche Boerse AG
Stocks
DC4
US2521311074
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 63.00 EUR | +1.94% |
|
-7.35% | +10.49% |
| 22/07 | Dexcom Insider Sold Shares Worth $2,041,999, According to a Recent SEC Filing | MT |
| 16/07 | Truist Adjusts Price Target on DexCom to $87 From $80, Maintains Buy Rating | MT |
Company Valuation: DexCom, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 52,042 | 43,740 | 47,945 | 30,377 | 25,885 | 27,196 | - | - |
| Change | - | -15.95% | 9.61% | -36.64% | -14.79% | 5.06% | - | - |
| Enterprise Value (EV) 1 | 52,692 | 45,068 | 49,813 | 31,073 | 26,209 | 26,768 | 25,916 | 24,813 |
| Change | - | -14.47% | 10.53% | -37.62% | -15.65% | 2.13% | -3.18% | -4.25% |
| P/E | 346x | 138x | 95.5x | 54.8x | 31.8x | 28.6x | 24x | 20x |
| PBR | 23.1x | 20.5x | 23.1x | 15.1x | 9.3x | 9.95x | 8.54x | 6.51x |
| PEG | - | 1x | 1.6x | 5.94x | 0.7x | 1.6x | 1.2x | 1x |
| Capitalization / Revenue | 21.3x | 15x | 13.2x | 7.53x | 5.55x | 5.21x | 4.67x | 4.18x |
| EV / Revenue | 21.5x | 15.5x | 13.8x | 7.7x | 5.62x | 5.12x | 4.45x | 3.81x |
| EV / EBITDA | 111x | 60x | 49.1x | 28.1x | 19.4x | 16.3x | 13.5x | 11.2x |
| EV / EBIT | 142x | 92.9x | 69.3x | 41x | 27x | 22.1x | 18x | 14.4x |
| EV / FCF | 989x | 148x | 97.3x | 49.3x | 24.3x | 26.9x | 20.9x | 16.4x |
| FCF Yield | 0.1% | 0.68% | 1.03% | 2.03% | 4.11% | 3.71% | 4.8% | 6.11% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.3875 | 0.82 | 1.3 | 1.42 | 2.09 | 2.46 | 2.939 | 3.532 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,448 | 2,910 | 3,622 | 4,033 | 4,662 | 5,224 | 5,827 | 6,507 |
| EBITDA 1 | 472.7 | 751.6 | 1,014 | 1,105 | 1,349 | 1,638 | 1,914 | 2,209 |
| EBIT 1 | 370.7 | 485.1 | 718.6 | 757.1 | 969.3 | 1,212 | 1,438 | 1,726 |
| Net income 1 | 154.7 | 341.2 | 541.5 | 576.2 | 836.3 | 959.5 | 1,157 | 1,383 |
| Net Debt 1 | 650.1 | 1,328 | 1,868 | 695.9 | 323.2 | -428.7 | -1,281 | -2,383 |
| Reference price 2 | 134.24 | 113.24 | 124.09 | 77.77 | 66.37 | 70.48 | 70.48 | 70.48 |
| Nbr of stocks (in thousands) | 3,87,688 | 3,86,258 | 3,86,374 | 3,90,595 | 3,90,016 | 3,85,873 | - | - |
| Announcement Date | 10/02/22 | 09/02/23 | 08/02/24 | 13/02/25 | 12/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 28.57x | 3.95x | 15.37x | 2.57% | 18TCr | |
| 18.61x | 3.27x | 11.49x | 3.63% | 10TCr | |
| 16.97x | 0.19x | 11.99x | 0.78% | 5.94TCr | |
| 31.34x | 7.61x | 19.89x | 1.28% | 5.07TCr | |
| 38.12x | 3.05x | 10.41x | 2.52% | 4.21TCr | |
| 36.08x | 1.33x | 11.7x | 0.27% | 3.18TCr | |
| 41.9x | 7.46x | 26.85x | 0.25% | 2.51TCr | |
| 23.19x | 3.39x | 12.2x | 1.25% | 2.05TCr | |
| 19.04x | 2.63x | 10.25x | 1.65% | 1.94TCr | |
| Average | 28.20x | 3.65x | 14.46x | 1.58% | 5.88TCr | |
| Weighted average by Cap. | 26.84x | 3.61x | 14.27x | 2.12% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DXCM Stock
- DC4 Stock
- Valuation DexCom, Inc.
Select your edition
All financial news and data tailored to specific country editions
